المؤلفون: Atrash S, Moyo TK

المصدر: OncoTargets and Therapy, Vol Volume 14, Pp 2185-2201 (2021)

مصطلحات موضوعية: multiple myeloma, relapsed, refractory, treatment, chimeric antigen receptor, t cells, cytokine release syndrome, lymphoma, leukemia., Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.dovepress.com/a-review-of-chimeric-antigen-receptor-t-cell-therapy-for-myeloma-and-l-peer-reviewed-article-OTT; https://doaj.org/toc/1178-6930

URL الوصول: https://doaj.org/article/f750e8df28954b8e8754dc9c7e56873f

المؤلفون: Moyo TK; Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC, United States., Vaidya R; Department of Hematology and Oncology, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston Salem, NC, United States.

المصدر: Frontiers in oncology [Front Oncol] 2024 Aug 15; Vol. 14, pp. 1397186. Date of Electronic Publication: 2024 Aug 15 (Print Publication: 2024).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Melody M; Northwestern University, Feinberg School of Medicine, Chicago, IL., Epperla N; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH., Shouse G; City of Hope Comprehensive Cancer Center, Duarte, CA., Romancik J; Winship Cancer Institute, Emory University, Atlanta, GA., Allen P; Winship Cancer Institute, Emory University, Atlanta, GA., Moyo TK; Levine Cancer Institute, Atrium Health, Charlotte, NC., Kenkre V; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI., Ollila T; Lifespan Cancer Institute, Brown University, Providence, RI., Fitzgerald L; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Hess B; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC., David K; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., Herr MM; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Odetola O; Northwestern University, Feinberg School of Medicine, Chicago, IL., Lin A; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Moreira J; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Ma S; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Winter JN; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Roy I; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL.; Shirley Ryan Ability Lab, Chicago, IL., Stephens D; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Danilov A; City of Hope Comprehensive Cancer Center, Duarte, CA., Shah NN; MCW Cancer Center, Medical College of Wisconsin, Milwaukee, WI., Barta SK; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Cortese M; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Cohen JB; Winship Cancer Institute, Emory University, Atlanta, GA., Gordon LI; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Karmali R; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL.

المصدر: Blood advances [Blood Adv] 2024 May 28; Vol. 8 (10), pp. 2327-2331.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, CD19*/immunology , Immunotherapy, Adoptive*/methods , Immunotherapy, Adoptive*/adverse effects, Humans ; Male ; Female ; Neoplasms, Second Primary/etiology ; Neoplasms, Second Primary/therapy ; Adult ; Receptors, Chimeric Antigen ; Middle Aged ; Neoplasms/therapy ; Neoplasms/immunology

المؤلفون: Karmali R; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Machhi R; Northwestern University, Feinberg School of Medicine, Chicago, IL., Epperla N; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH., Shouse G; City of Hope Comprehensive Cancer Center, Duarte, CA., Romancik J; Winship Cancer Institute, Emory University, Atlanta, GA., Moyo TK; Atrium Health Levine Cancer Institute, Charlotte, NC., Kenkre V; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI., Ollila TA; Lifespan Cancer Institute, Brown University, Providence, RI., Fitzgerald L; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Hess B; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC., David K; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., Roy I; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Zurko J; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI., Chowdhury SM; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH., Annunzio K; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH., Ferdman R; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Bhansali RS; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Harris EI; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI., Liu J; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., Nizamuddin I; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Ma S; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Moreira J; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Winter J; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Pro B; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Stephens DM; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Danilov A; City of Hope Comprehensive Cancer Center, Duarte, CA., Shah NN; MCW Cancer Center, Medical College of Wisconsin, Milwaukee, WI., Cohen JB; Winship Cancer Institute, Emory University, Atlanta, GA., Barta SK; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Torka P; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Gordon LI; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL.

المصدر: Blood advances [Blood Adv] 2024 May 28; Vol. 8 (10), pp. 2592-2599.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Social Determinants of Health* , Immunotherapy, Adoptive*, Humans ; Male ; Female ; Middle Aged ; Adult ; Lymphoma, B-Cell/therapy ; Lymphoma, B-Cell/mortality ; Treatment Outcome ; Aged ; United States ; Retrospective Studies ; Racial Groups

المؤلفون: Hamadeh IS; Department of Cancer Pharmacology and Pharmacogenomics, Atrium Health Levine Cancer Institute, Charlotte, North Carolina., Patel JN; Department of Cancer Pharmacology and Pharmacogenomics, Atrium Health Levine Cancer Institute, Charlotte, North Carolina., Jacobs R; Department of Hematologic Malignancies and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, North Carolina., Zeng H; Department of Cancer Biostatistics, Atrium Health Levine Cancer Institute, Charlotte, North Carolina., He J; Department of Cancer Biostatistics, Atrium Health Levine Cancer Institute, Charlotte, North Carolina., Hu B; Department of Hematologic Malignancies and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, North Carolina., Moyo TK; Department of Hematologic Malignancies and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, North Carolina., Soni A; Department of Hematologic Malignancies and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, North Carolina., Park S; Department of Hematologic Malignancies and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, North Carolina., Copelan E; Department of Hematologic Malignancies and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, North Carolina., Avalos B; Department of Hematologic Malignancies and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, North Carolina., Hamilton A; Molecular Biology and Genomics Core Facility, Atrium Health Levine Cancer Institute, Charlotte, North Carolina., Steuerwald N; Molecular Biology and Genomics Core Facility, Atrium Health Levine Cancer Institute, Charlotte, North Carolina., Ghosh N; Department of Hematologic Malignancies and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, North Carolina.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Dec 01; Vol. 29 (23), pp. 4941-4948.

نوع المنشور: Observational Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy , Leukemia, Lymphocytic, Chronic, B-Cell*/genetics, Humans ; Retrospective Studies ; KCNQ1 Potassium Channel ; Piperidines/therapeutic use ; Protein Kinase Inhibitors/therapeutic use

المؤلفون: Moyo TK; Atrium Health Levine Cancer Institute, 1021 Morehead Medical Drive, Bldg II, Suite 60100, Charlotte, NC 28204.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2023 Aug; Vol. 29 (8), pp. 480-481.

نوع المنشور: Journal Article; Comment

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, B-Cell*/therapy , Lymphoma, Non-Hodgkin*/pathology, Humans ; Neoplasm Recurrence, Local ; Stem Cell Transplantation

المؤلفون: Moyo TK; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.; Levine Cancer Institute, Charlotte, North Carolina., Kishtagari A; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Villaume MT; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee., McMahon B; University of Colorado, Denver, Colorado., Mohan SR; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Stopczynski T; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Center for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee., Chen SC; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Center for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee., Fan R; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Center for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee., Huo Y; Department of Electrical and Computer Engineering, Vanderbilt University School of Medicine, Nashville, Tennessee., Moon H; Department of Electrical and Computer Engineering, Vanderbilt University School of Medicine, Nashville, Tennessee., Tang Y; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee., Bejan CA; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee., Childress M; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee., Anderson I; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Rawling K; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Simons RM; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Moncrief A; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Caza R; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Dugger L; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Collins A; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Dudley CV; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Ferrell PB; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.; Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee.; Center for Immunobiology, Vanderbilt University School of Medicine, Nashville, Tennessee., Byrne M; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Strickland SA; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Ayers GD; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Center for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee., Landman BA; Department of Electrical and Computer Engineering, Vanderbilt University School of Medicine, Nashville, Tennessee.; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee., Mason EF; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee., Mesa RA; Wake Forest Baptist Cancer Center, Winston-Salem, North Carolina., Palmer JM; Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona., Michaelis LC; Medical College of Wisconsin, Madison, Wisconsin., Savona MR; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.; Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee.; Center for Immunobiology, Vanderbilt University School of Medicine, Nashville, Tennessee.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jul 05; Vol. 29 (13), pp. 2375-2384.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Primary Myelofibrosis*/drug therapy , Primary Myelofibrosis*/metabolism , Janus Kinase Inhibitors*/therapeutic use, Humans ; Aged ; Phosphatidylinositol 3-Kinases ; Pyrimidines/therapeutic use ; Nitriles/therapeutic use

المؤلفون: Zurko J; Department of Medicine, Carbone Cancer Center, University of Wisconsin, Madison, WI., Nizamuddin I; Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL., Epperla N; Department of Internal Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH., David K; Department of Medicine, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., Cohen JB; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA., Moyo TK; Atrium Health Carolinas Medical Center, Charlotte, NC., Ollila T; Department of Medicine, Lifespan Cancer Institute, Brown University, Providence, RI., Hess B; Department of Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC., Roy I; Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL., Ferdman R; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Liu J; Department of Medicine, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., Chowdhury SM; Department of Internal Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH., Romancik J; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA., Bhansali RS; Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Harris EI; Department of Medicine, Carbone Cancer Center, University of Wisconsin, Madison, WI., Sorrell M; Department of Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC., Masel R; Department of Medicine, Lifespan Cancer Institute, Brown University, Providence, RI., Kittai AS; Department of Internal Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH., Denlinger N; Department of Internal Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH., Sigmund AM; Department of Internal Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH., Fitzgerald L; Department of Internal Medicine, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Galvez C; Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL., Ma S; Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL., Winter J; Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL., Pro B; Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL., Gordon LI; Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL., Danilov A; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA., Stephens D; Department of Internal Medicine, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Shah NN; Department of Medicine, MCW Cancer Center, Medical College of Wisconsin, Milwaukee, WI., Kenkre V; Department of Medicine, Carbone Cancer Center, University of Wisconsin, Madison, WI., Barta SK; Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Torka P; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Shouse G; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA., Karmali R; Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL.

المصدر: Blood advances [Blood Adv] 2023 Jun 27; Vol. 7 (12), pp. 2657-2669.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Chimeric Antigen*/therapeutic use , Lymphoma, B-Cell*, Humans ; Retrospective Studies ; Immunotherapy, Adoptive/methods ; Progression-Free Survival

المؤلفون: Epperla N; Division of Hematology, The Ohio State University, Columbus, OH., Zhao Q; Division of Hematology, The Ohio State University, Columbus, OH., Chowdhury SM; Division of Hematology, The Ohio State University, Columbus, OH., Shea L; Division of Hematology, Washington University, St. Louis, MO., Moyo TK; Levine Cancer Center, Atrium Health, Charlotte, NC., Reddy N; Vanderbilt University Medical Center, Nashville, TN., Sheets J; Division of Hematology and Oncology, University of North Carolina, Chapel Hill, NC., Weiner DM; Division of Hematology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Geethakumari PR; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Kandarpa M; Division of Hematology, Rogel Cancer Center, University of Michigan, Ann Arbor, MI., Bruno XJ; Division of Hematology and Oncology, University of Vermont, Burlington, VT., Thomas C; Division of Hematology, Thomas Jefferson University, Philadelphia, PA., Churnetski MC; Winship Cancer Institute, Emory University Medical Center, Atlanta, GA., Hsu A; Division of Hematology, Brown University, Providence, RI., Zurbriggen L; Division of Hematology, University of Wisconsin, Madison, WI., Tan XC; Cancer Institute of New Jersey, New Brunswick, NJ., Lindsey K; Division of Hematology and Oncology, Medical University of South Carolina, Charleston, SC., Maakaron J; Division of Hematology, University of Minnesota, Minneapolis, MN., Caimi PF; University Hospitals Seidman Cancer Center, Cleveland, OH., Torka P; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY., Bello C; Division of Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Ayyappan S; Division of Hematology and Oncology, University of Iowa, Iowa City, IA., Oh TS; Division of Hematology, Northwestern University, Chicago, IL., Karmali R; Division of Hematology, Northwestern University, Chicago, IL., Kim SH; Division of Hematology and Oncology, Rush University, Chicago, IL., Kress A; Division of Hematology, Yale University, New Haven, CT., Kothari S; Division of Hematology, Yale University, New Haven, CT., Sawalha Y; Division of Hematology, The Ohio State University, Columbus, OH., Christian B; Division of Hematology, The Ohio State University, Columbus, OH., David KA; Cancer Institute of New Jersey, New Brunswick, NJ., Greenwell IB; Division of Hematology and Oncology, Medical University of South Carolina, Charleston, SC., Janakiram M; Division of Hematology, University of Minnesota, Minneapolis, MN., Kenkre VP; Division of Hematology, University of Wisconsin, Madison, WI., Olszewski AJ; Division of Hematology, Brown University, Providence, RI., Cohen JB; Winship Cancer Institute, Emory University Medical Center, Atlanta, GA., Palmisiano N; Division of Hematology, Thomas Jefferson University, Philadelphia, PA., Umyarova E; Division of Hematology and Oncology, University of Vermont, Burlington, VT., Wilcox RA; Division of Hematology, Rogel Cancer Center, University of Michigan, Ann Arbor, MI., Awan FT; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Alderuccio JP; Division of Hematology, University of Miami, Miami, FL., Barta SK; Division of Hematology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Grover NS; Division of Hematology and Oncology, University of North Carolina, Chapel Hill, NC., Ghosh N; Levine Cancer Center, Atrium Health, Charlotte, NC., Bartlett NL; Division of Hematology, Washington University, St. Louis, MO., Herrera AF; Division of Hematology, City of Hope, Duarte, CA., Shouse G; Division of Hematology, City of Hope, Duarte, CA.

المصدر: Blood advances [Blood Adv] 2023 Jan 10; Vol. 7 (1), pp. 88-91.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasm Recurrence, Local*/drug therapy , Lymphoma, B-Cell, Marginal Zone*/drug therapy , Lymphoma, B-Cell, Marginal Zone*/pathology, Humans ; Disease-Free Survival ; Chronic Disease

المؤلفون: Moyo TK; Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN, 777 PRB, USA.; Levine Cancer Institute, Charlotte, NC, USA., Mendler JH; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA., Itzykson R; Paris Diderot University, Paris, France., Kishtagari A; Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN, 777 PRB, USA., Solary E; Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France., Seegmiller AC; Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN, 777 PRB, USA., Gerds AT; Cleveland Clinic, Cleveland, OH, USA., Ayers GD; Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN, 777 PRB, USA., Dezern AE; Johns Hopkins University, Baltimore, MD, USA., Nazha A; Cleveland Clinic, Cleveland, OH, USA., Valent P; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., van de Loosdrecht AA; VU University Medical Center, Amsterdam, Netherlands., Onida F; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy., Pleyer L; Third Medical Department With Hematology, Medical Oncology, Rheumatology and Infectiology, Paracelsus Medical University, Salzburg, Austria.; Salzburg Cancer Research Institute Center for Clinical Cancer and Immunology Trials, Salzburg, Austria., Cirici BX; Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Bellaterr, Spain., Tibes R; Mayo Clinic, Scottsdale, AZ, USA., Geissler K; Sigmund Freud University, Vienna, Austria., Komrokji RS; H. Lee Moffitt Cancer Center, Tampa, FL, USA., Zhang J; University of Wisconsin-Madison, Madison, WI, USA., Germing U; Department of Hematology, Oncology, and Clinical Immunology, University of Duesseldorf, Duesseldorf, Germany., Steensma DP; Dana-Farber Cancer Institute, Boston, MA, USA., Wiseman DH; University of Manchester, Manchester, UK., Pfeilstöecker M; Hanusch Hospital and Ludwig Boltzmann Institute for Hematology and Oncology, Vienna, Austria., Elena C; University of Pavia, Pavia, Italy., Cross NCP; School of Medicine, University of Southampton, Southampton, UK., Kiladjian JJ; Université de Paris, APHP, Hôpital Saint-Louis, Centre d'Investigations Cliniques, INSERM CIC 1427, Paris, France., Luebbert M; University of Freiburg, Freiburg, Germany., Mesa RA; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Montalban-Bravo G; MD Anderson Cancer Center, Houston, TX, USA., Sanz GF; Hospital Universitario Y Politécnico La Fe, Valencia, Spain., Platzbecker U; University Hospital Leipzig, Leipzig, Germany., Patnaik MM; Mayo Clinic, Rochester, MN, USA., Padron E; H. Lee Moffitt Cancer Center, Tampa, FL, USA., Santini V; MDS UNIT, University of Florence, HematologyFlorence, Italy., Fenaux P; Paris Diderot University, Paris, France., Savona MR; Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN, 777 PRB, USA. michael.savona@vanderbilt.edu.

مؤلفون مشاركون: MDS/MPN International Working Group

المصدر: BMC cancer [BMC Cancer] 2022 Sep 24; Vol. 22 (1), pp. 1013. Date of Electronic Publication: 2022 Sep 24.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Myelodysplastic-Myeloproliferative Diseases* , Quality of Life*, Acetonitriles ; Cytidine Deaminase ; DNA/therapeutic use ; Decitabine/therapeutic use ; Humans ; Methyltransferases ; Prospective Studies ; Pyrazoles ; Pyrimidines ; Pyrroles ; Syndrome